rec15 Antibody

Shipped with Ice Packs
In Stock

Description

Research Applications of LRRC15 Antibodies

Validated antibody clones and their applications:

Antibody CloneHost SpeciesApplicationsTarget ValidationSource
ab151501RabbitWB, IHC-P, IPRECQ1 co-IP validation Abcam
MAB11324RabbitWB (104 kDa detection)U-87 MG glioblastoma lysates R&D Systems
CC6-469RatFlow cytometryHuman LRRC15 epitope mapping BD Biosciences

Key findings:

  • LRRC15 antibodies enable detection in formalin-fixed paraffin-embedded (FFPE) tissues with EDTA-based antigen retrieval .

  • Flow cytometry confirms surface expression in 85% of osteosarcoma cell lines .

Antibody-Drug Conjugates (ADCs)

LRRC15-targeted ADCs demonstrate differential efficacy:

ADCPayloadEC50 (nM)Cure Rate (SaOS2 xenografts)Resistance Development
LRRC15-MMAEMonomethyl auristatin E12.440%After 7 passages
LRRC15-PNUPNU-1596823.8100%No resistance observed

Mechanistic insights:

  • MMAE payload shows innate sensitivity in LRRC15-high cell lines (IC50 reduction >60% vs controls) .

  • PNU payload exhibits bystander effect through membrane permeability, enhancing tumor penetration .

Combination Therapies

  • TGF-β pretreatment increases LRRC15 expression in low-expressing cells by 4.2-fold (p<0.001), enabling ADC sensitization .

  • Triple antibody combinations (REGN10933+REGN10987+REGN10985) prevent viral escape in SARS-CoV-2 models .

Clinical Validation

  • ABBV-085 (anti-LRRC15-MMAE):

    • Phase I trial (NCT02565758): 20% response rate in osteosarcoma patients .

    • Preclinical EC50: 0.11 µg/mL in pancreatic cancer models .

  • REGEN-COV (casirivimab+imdevimab):

    • 40% reduction in COVID-19 hospitalizations vs placebo (HR=0.60, 95% CI 0.45–0.81) .

Characterization Challenges

The "antibody crisis" highlights critical validation requirements :

  1. Genetic validation: KO cell line confirmation (e.g., CRISPR-edited LRRC15−/− controls).

  2. Orthogonal methods: Concordance between WB, IHC, and flow cytometry .

  3. Epitope mapping: CC6-469 recognizes extracellular LRR domain (aa 45-128) .

Emerging Directions

  • Biomarker potential: LRRC15+ stromal density correlates with poor prognosis (HR=2.1, p=0.008 in pancreatic cancer) .

  • Immune modulation: LRRC15 knockdown increases CD8+ T-cell infiltration by 38% in murine models .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
rec15 antibody; SPBC1711.14 antibody; Meiotic recombination protein rec15 antibody
Target Names
rec15
Uniprot No.

Target Background

Function
Rec15 antibody plays a crucial role in the early stages of meiosis, specifically in meiotic recombination. It is also involved in chromosome segregation, where it is essential for the separation of sister chromatids across all three chromosomes.
Gene References Into Functions
  1. Studies on rec15 mutants have revealed an early onset of meiotic events. This observation is unique for an early meiotic recombination mutant and suggests a function for the Rec15 protein at or before DNA synthesis. [rec15] PMID: 16252089
Database Links
Subcellular Location
Nucleus.

Q&A

What is RECQL5 and what cellular functions does it perform?

RECQL5 is a DNA helicase that plays important roles in DNA replication, transcription, and repair . It belongs to the RecQ family of helicases and typically unwinds DNA in a 3'-5' direction . RECQL5's cellular functions include:

  • Binding to RNA polymerase II subunit POLR2A during transcription elongation to suppress transcription-associated genomic instability

  • Associating with POLR1A to enforce stability of ribosomal DNA arrays

  • Removing RAD51 filaments that protect stalled replication forks at common fragile sites

  • Stimulating MUS81-EME1 endonuclease activity for mitotic DNA synthesis

  • Playing critical roles in mitotic chromosome separation after crossover events

  • Preventing sister chromatid exchange and regulating homologous recombination

These diverse functions highlight RECQL5's central importance in maintaining genomic stability across multiple cellular processes.

What experimental applications are most suitable for RECQL5 antibodies?

RECQL5 antibodies have been validated for several key experimental applications, each providing unique insights into RECQL5 biology:

  • Immunohistochemistry on paraffin-embedded tissues (IHC-P): Visualizes RECQL5 distribution in tissues

  • Western blotting (WB): Detects RECQL5 protein levels and potential post-translational modifications

  • Immunocytochemistry/Immunofluorescence (ICC/IF): Reveals subcellular localization in fixed cells

  • Immunoprecipitation (IP): Isolates RECQL5 and interacting partners from complex mixtures

When selecting an application, researchers should verify that their specific antibody has been validated for that technique, as antibody performance can vary significantly between applications. Currently available commercial antibodies include both polyclonal and monoclonal options targeting various RECQL5 epitopes .

How should researchers select between polyclonal and monoclonal RECQL5 antibodies?

The choice between polyclonal and monoclonal RECQL5 antibodies depends on the specific research application:

Antibody TypeAdvantagesLimitationsBest Applications
Polyclonal (e.g., HPA029971) Recognizes multiple epitopes
Higher sensitivity
More tolerant of protein denaturation
Batch-to-batch variability
Higher background in some applications
Western blotting
IHC of fixed tissues
Initial protein detection
MonoclonalConsistent specificity
Lower background
Better reproducibility
May lose reactivity if epitope is modified
Sometimes lower sensitivity
Quantitative assays
Co-IP experiments
Long-term studies requiring consistency
RecombinantHighest reproducibility
Defined sequence
Renewable resource
Higher initial cost
May require optimization
All applications where reproducibility is critical

For critical experiments, researchers should validate results with both polyclonal and monoclonal antibodies targeting different RECQL5 epitopes. The growing emphasis on recombinant antibodies addresses the reproducibility concerns in antibody-based research .

Why is proper validation of RECQL5 antibodies critical for research?

Proper validation of RECQL5 antibodies is essential because approximately 50% of commercial antibodies fail to meet basic standards for characterization, contributing to an estimated $0.4-1.8 billion in annual financial losses in the United States alone . For RECQL5 research specifically, validation is critical because:

  • RECQL5 shares sequence homology with other RecQ family helicases, increasing the risk of cross-reactivity

  • Multiple isoforms of RECQL5 exist, requiring antibodies that can distinguish between them

  • RECQL5's involvement in multiple cellular processes means non-specific antibodies could lead to misinterpretation of biological functions

The International Working Group for Antibody Validation has established "five pillars" of antibody validation :

  • Genetic strategies (knockout/knockdown controls)

  • Orthogonal strategies (antibody-independent methods)

  • Independent antibody validation (multiple antibodies to same target)

  • Expression of recombinant tagged proteins

  • Immunocapture with mass spectrometry

Implementing at least two of these validation approaches significantly improves research reliability and reproducibility .

How can researchers optimize Western blot protocols for specific RECQL5 detection?

Optimizing Western blot protocols for RECQL5 detection requires attention to several key parameters:

Sample Preparation:

  • Use RIPA or NP-40 lysis buffers with protease inhibitors

  • Include benzonase or sonication to release chromatin-bound RECQL5

  • Heat samples at 95°C for 5 minutes in standard Laemmli buffer

Gel Electrophoresis and Transfer:

  • Use 7.5-8% gels for optimal resolution of RECQL5 (~108 kDa)

  • Transfer at 30V overnight at 4°C for large proteins like RECQL5

  • Use PVDF membranes for better protein retention

Antibody Incubation:

  • Block with 5% non-fat milk in TBST for 1 hour at room temperature

  • Dilute primary antibody to manufacturer's recommended concentration (typically 0.4 μg/ml for polyclonal antibodies)

  • Incubate with primary antibody overnight at 4°C

  • Use HRP-conjugated secondary antibodies with extended washing steps

Essential Controls:

  • Positive control: Cell lines with confirmed RECQL5 expression (HeLa)

  • Negative control: RECQL5 knockdown or knockout samples

  • Loading control: Probing for housekeeping proteins (β-actin, GAPDH)

These optimizations enhance specificity and sensitivity for RECQL5 detection while minimizing background and non-specific signals.

What experimental approaches can reveal RECQL5's interactions with transcription machinery?

RECQL5 interacts with transcription machinery, particularly with RNA polymerase II subunit POLR2A . To study these interactions:

Biochemical Interaction Studies:

  • Co-immunoprecipitation using antibodies against RECQL5 or POLR2A

  • GST pull-down assays with recombinant RECQL5 and nuclear extracts

  • Proximity ligation assay (PLA) to visualize interactions in situ

  • FRET or BiFC assays with fluorescently tagged proteins

Chromatin Association Analysis:

  • Chromatin immunoprecipitation (ChIP) to identify RECQL5 binding sites

  • ChIP-seq for genome-wide analysis of RECQL5 chromatin association

  • Re-ChIP to identify loci bound by both RECQL5 and POLR2A

  • ChIP-qPCR at specific transcriptionally active regions

Functional Impact Assessment:

  • Transcription elongation assays with/without RECQL5

  • RNA-seq comparing wild-type vs. RECQL5 knockout/knockdown

  • Nascent RNA analysis using EU incorporation or GRO-seq

  • POLR2A phosphorylation state analysis in RECQL5-depleted cells

These complementary approaches provide mechanistic insights into how RECQL5 interacts with and regulates the transcription machinery, supporting its role in suppressing transcription-associated genomic instability .

What controls are essential when using RECQL5 antibodies in research?

Essential controls for RECQL5 antibody experiments ensure reliable and reproducible results:

Universal Controls for All Applications:

  • Genetic validation: Use RECQL5 knockout or knockdown samples as negative controls

  • Positive control: Cell lines with confirmed RECQL5 expression

  • Loading/processing controls: Appropriate for each technique

Application-Specific Controls:

ApplicationEssential ControlsPurpose
Western BlotLoading control (β-actin)
Molecular weight marker
Peptide competition
Normalize protein loading
Confirm expected size
Verify specificity
IHC/ICCIsotype control antibody
RECQL5-depleted samples
Omit primary antibody
Assess non-specific binding
Confirm specificity
Evaluate secondary antibody background
ChIPInput sample (1-5%)
IgG control
Known target region
Normalization reference
Background binding assessment
Verify ChIP efficiency
IPInput sample (5-10%)
IgG control
Reciprocal IP
Confirm target presence
Assess non-specific binding
Validate interactions

Orthogonal Validation:

  • Compare antibody-based results with orthogonal methods

  • Use multiple antibodies targeting different RECQL5 epitopes

Implementing these controls helps distinguish genuine RECQL5-specific signals from technical artifacts, substantially improving data reliability.

How should researchers design experiments to study RECQL5's role in DNA repair?

Designing experiments to study RECQL5's role in DNA repair requires multi-faceted approaches:

Experimental System Selection:

  • Cell models: Cancer cell lines, primary cells, isogenic knockout lines

  • DNA damage induction: Select agents relevant to RECQL5's functions

    • Inter-strand crosslinks: Mitomycin C (RECQL5 is required for repair)

    • Replication stress: Hydroxyurea (affects RECQL5's interaction with stalled forks)

    • Double-strand breaks: Ionizing radiation, etoposide

RECQL5 Manipulation Strategies:

  • Loss-of-function: siRNA knockdown, CRISPR knockout, dominant-negative mutants

  • Complementation: Rescue experiments with wild-type or mutant RECQL5

  • Domain analysis: Expression of truncated RECQL5 constructs

Key Readouts:

  • DNA damage markers: γH2AX foci formation and resolution

  • Repair protein recruitment: RAD51 focus dynamics

  • Genomic instability markers: Micronuclei, chromosomal aberrations

  • Cell survival: Clonogenic assays following DNA damage

  • Sister chromatid exchange rates (RECQL5 prevents excessive exchange)

Interaction Studies:

  • Co-immunoprecipitation with DNA repair proteins

  • Recruitment kinetics to damage sites using live-cell imaging

  • ChIP-seq to identify genomic locations of RECQL5 recruitment after damage

These approaches provide complementary insights into RECQL5's specific functions in various DNA repair pathways and its contributions to genomic stability.

How can researchers distinguish between specific and non-specific binding when using RECQL5 antibodies?

Distinguishing specific from non-specific binding is crucial for reliable RECQL5 antibody experiments:

Critical Control Experiments:

  • Genetic validation: Compare signal between wild-type and RECQL5 knockout/knockdown samples

  • Peptide competition: Pre-incubate antibody with immunizing peptide to block specific binding

  • Multiple antibody comparison: Test several antibodies targeting different RECQL5 epitopes

  • Orthogonal validation: Compare results with antibody-independent methods

Specific vs. Non-specific Signal Characteristics:

ApplicationSpecific SignalNon-specific SignalValidation Method
Western BlotSingle band at ~108 kDaMultiple bands, unexpected sizesKnockout control, size verification
IHC/ICCPrimarily nuclear patternDiffuse staining, unexpected locationsKnockout control, pattern consistency
ChIPEnrichment at functional sitesUniform binding, enrichment at repetitive regionsKnockout control, IgG comparison
IPEnrichment of known partners (POLR2A) Common contaminants, non-reproducible interactionsKnockout control, reciprocal IP

Quantitative Approaches:

  • Calculate signal-to-noise ratios between specific and control samples

  • Perform dose-response experiments with increasing antibody concentrations

  • Compare signals across multiple biological replicates for consistency

These systematic approaches help researchers confidently distinguish genuine RECQL5 signals from artifacts, substantially improving data reliability and reproducibility.

What are common pitfalls in interpreting RECQL5 localization data?

Interpreting RECQL5 localization data presents several potential pitfalls that researchers should address:

Technical Artifacts:

  • Fixation effects: Different fixation methods can alter apparent localization

  • Antibody specificity: Non-validated antibodies may show misleading patterns

  • Signal intensity issues: Overexposure can mask genuine localization patterns

  • Cross-reactivity: Antibodies may detect related RecQ helicases

Biological Variables Affecting Interpretation:

  • Cell cycle dependence: RECQL5 localization changes throughout the cell cycle

  • DNA damage response: RECQL5 redistributes upon DNA damage induction

  • Cell type differences: Expression and localization may vary between tissues

  • Protein interactions: Binding partners may mask antibody epitopes

Mitigation Strategies:

  • Use multiple antibodies targeting different RECQL5 epitopes

  • Include RECQL5 knockout/knockdown controls in every experiment

  • Perform co-localization with known RECQL5 interactors (POLR2A, TOP2A)

  • Analyze multiple cells and fields rather than selecting "representative" images

  • Quantify localization patterns using unbiased image analysis methods

  • Document precise fixation and immunostaining protocols

Complementary Approaches:

  • Combine fixed-cell immunofluorescence with live-cell imaging of tagged RECQL5

  • Correlate localization with functional assays (e.g., DNA repair capacity)

  • Use biochemical fractionation to confirm microscopy-based localization

How should researchers quantify RECQL5 expression levels in different experimental systems?

Accurate quantification of RECQL5 expression requires appropriate methodologies for each experimental system:

Western Blot Quantification:

  • Use digital image acquisition systems rather than film for better linearity

  • Include standard curves with recombinant RECQL5 for semi-quantitative analysis

  • Normalize to total protein staining rather than single housekeeping proteins

  • Apply appropriate background subtraction methods

  • Report fold-changes rather than absolute values when comparing samples

Immunofluorescence Quantification:

  • Use consistent acquisition parameters across all samples

  • Measure nuclear RECQL5 intensity within DAPI-positive regions

  • Analyze large cell populations (n>100) rather than selected fields

  • Report distribution of values (not just means) to capture heterogeneity

  • Use automated image analysis workflows to reduce bias

qPCR for mRNA Quantification:

  • Design primers specific to RECQL5 with validated efficiency

  • Use multiple reference genes for normalization

  • Account for all known RECQL5 transcript variants

  • Report results as fold-changes relative to appropriate controls

Comparison of Quantification Methods:

MethodAdvantagesLimitationsBest Applications
Western BlotDetects protein directly
Distinguishes isoforms
Limited dynamic range
Semi-quantitative
Comparing experimental conditions
ImmunofluorescenceSingle-cell resolution
Spatial information
Subjective without proper analysisHeterogeneity studies, localization
qPCRHigh sensitivity
Good dynamic range
Measures mRNA not proteinTranscriptional regulation studies
Flow CytometryHigh-throughput
Single-cell analysis
Requires optimization for nuclear proteinsPopulation analysis, cell sorting

Combining multiple complementary quantification methods provides the most robust assessment of RECQL5 expression levels across different experimental systems.

How can researchers ensure reproducibility when working with RECQL5 antibodies?

Ensuring reproducibility with RECQL5 antibodies requires systematic attention to multiple factors:

Antibody Selection and Documentation:

  • Preferentially use recombinant antibodies for highest reproducibility

  • Document complete antibody information: manufacturer, catalog number, lot number, concentration

  • Verify antibody validation status using established criteria

  • Create working aliquots to avoid freeze-thaw cycles

Protocol Standardization:

  • Develop detailed standard operating procedures (SOPs)

  • Specify all buffer compositions, incubation times and temperatures

  • Document equipment settings (imagers, microscopes, etc.)

  • Implement quality control checkpoints throughout workflows

Validation and Controls:

  • Validate antibodies in each specific experimental system

  • Include positive and negative controls in every experiment

  • Use orthogonal methods to confirm key findings

  • Test multiple antibody lots when possible

Reporting and Data Sharing:

  • Provide comprehensive methods sections including all validation steps

  • Share raw data and analysis workflows

  • Document image acquisition parameters completely

  • Consider publishing antibody validation data as supplementary material

The growing emphasis on recombinant antibodies addresses many reproducibility challenges, as these reagents offer consistent performance across experiments and between laboratories . For research using RECQL5 antibodies specifically, implementing these best practices helps ensure that findings are robust and reproducible.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.